PXAI
v8.42
Feed
Viral
World
Politics
Technology
Daily Briefing
Sources
|
ToS
Version History
Version
Description
Date
8.42
[ADDED SOURCE REGISTRY LIST VIEW]
04/03/2026 16:19
8.41
[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]
04/03/2026 16:11
8.40
[TRANSLATED FRONTEND TO US ENGLISH]
04/03/2026 16:10
8.41
[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]
04/03/2026 15:50
8.41
[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]
04/03/2026 15:46
8.40
[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]
04/03/2026 15:40
8.39
[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]
04/03/2026 15:38
8.38
[TRANSLATED SOURCES VIEW TO US ENGLISH]
04/03/2026 15:01
8.37
[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]
04/03/2026 14:58
8.67
[MANUAL OVERRIDE OF GREEK MENU ITEMS]
04/03/2026 13:36
8.66
[NGINX OPTIMIZED MENU FIX]
04/03/2026 13:33
8.65
[FIXED GREEK MENU ITEMS]
04/03/2026 13:32
8.60
[MENU & UI LOCALIZATION TO US ENGLISH]
04/03/2026 13:30
8.50
[FULL TRANSLATION TO US ENGLISH]
04/03/2026 13:27
9.75
[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]
26/02/2026 14:44
PXAI Audio Feed
+5
ΟΛΑ
31/03 19:36
yahoo.com
Jim Cramer on ImmunityBio: “I Would Encourage You to Own It, Provided You Don’t Own Any Other Spec”
Jim Cramer
ImmunityBio
stock recommendation
biotech
investment advice
diversification
31/03 19:28
yahoo.com
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
Agios Pharmaceuticals
stock surge
biotech
oncology pipeline
clinical trial
partnership
31/03 18:06
yahoo.com
RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 – Here’s Why
RBC Capital
Legend Biotech
price target
earnings
valuation
regulatory approvals
31/03 18:06
yahoo.com
Wells Fargo Lifts PT on Liquidia Corporation (LQDA) to $51 From $44 – Here’s Why
Wells Fargo
Liquidia
price target
biotech
earnings outlook
product pipeline
31/03 18:06
yahoo.com
Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now
Alnylam
RNAi
high‑growth
biotech
healthcare stocks
gene therapy
31/03 18:06
yahoo.com
Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 – Here’s Why
BridgeBio Pharma
Mizuho
price target
pipeline
positive trial data
strategic partnerships
31/03 18:06
yahoo.com
Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why
Insmed
Stifel
price target
earnings outlook
pipeline
stock upgrade
31/03 18:06
yahoo.com
BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why
BioNTech
BMO Capital
price target
vaccine demand
earnings outlook
competition
31/03 18:00
statnews.com
STAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor
gene editing
FDA regulation
custom therapies
rare diseases
manufacturing challenges
Baby KJ
31/03 18:00
statnews.com
STAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor
gene editing
FDA regulation
custom therapies
rare diseases
manufacturing challenges
Baby KJ
Comments
Loading...
Send
Dev Changelog
v8.42
No logs found in database.
0
Display Settings
Size
Aa
Brightness
Theme
Dark
Comments